ASCO	American Society of Clinical Oncology
BTC	Biliary tract cancer
CCA	Cholangiocarcinoma
cfDNA	Circulating free DNA
ctDNA	Circulating tumor DNA
ESCAT	ESMO Scale of Actionability of Molecular Targets
ESMO	European Society of Medical Oncology
ERBB2	Epidermal growth factor receptor 2
FGFR2	Fibroblast growth factor receptor 2
GBC	Gallbladder cancer
GEC	Gastroesophageal adenocarcinoma
MRD	Minimal residual disease
MSI-H	Microsatellite instability—high
NGS	Next-generation sequencing
NTRK	Neurotrophic tyrosine receptor kinase
OS	Overall survival
PCR	Polymerase chain reaction
PDAC	Pancreatic ductal adenocarcinoma
PFS	Progression-free survival
VAF	Tumor somatic variant allelic frequency